ADMA regulates angiogenesis: Genetic and metabolic evidence

Vascular Medicine

Volumn 10, Issue 1, 2005, Pages 7-14

  Achan, V ^a,b   Ho, H K ^a   Heeschen, C ^a   Stuehlinger, M ^a   Jang, J J ^a   Kimoto, M ^c   Vallance, P ^b   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Dimethylarginine dimethylaminohydrolase; Endothelium; Ischemia; Nitric oxide; Peripheral arterial disease

Indexed keywords

APOLIPOPROTEIN E; ARGININE; DIMETHYLARGININASE; N(G) NITROARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINDLIMB; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LIMB ISCHEMIA; MEASUREMENT; MOUSE; MOUSE STRAIN; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TISSUE LEVEL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARGININE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; HYPERCHOLESTEROLEMIA; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE;

EID: 18744388378     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x05vm580oa     Document Type: Article

References (31)

1. Ziche M, Morbidelli L, Choudburi R et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34.
2. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998; 82: 1007-15.
3. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-39.
4. Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-78.
5. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (suppl 12): S60-62.
6. Boger RH, Bode-Boger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 1998; 98: 1842-47.
7. Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996; 219: 598-603.
8. Boger RH, Bode-Boger SM, Brandes RP et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation 1997; 96: 1282-90.
9. MacAllister RJ, Fickling SA, Whitley GSJ, Vallance P. Metabolism of methylarginines by human vasculature: implications for the regulation of nitric oxide synthesis. Br J Pharmacol 1994; 112: 43-48.
10. MacAllister RJ, Parry H, Kimoto M et al. Regulation of nitric oxide synthesis by dimethylarginine dimethyl-aminohydrolase. Br J Pharmacol 1996; 119: 1533-40.
11. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-95.
12. Plump AS, Smith JD, Hayek T et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-53.
13. Dayoub H, Achan V, Adimoolam S et al. DDAH regulates NO synthesis: genetic and physiological evidence. Circulation 2003; 108: 1043-48.
14. Heeschen C, Jang J, Hoai-Ky V et al. Nicotine is an agent of angiogenesis. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7: 833-39.
15. Rivard A, Fabre J-E, Silver M et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-20.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
17. Tatchum-Talom R, Schulz R, McNeill JR, Khadour FH. Upregulation of neuronal nitric oxide synthase in skeletal muscle by swim training. Am J Physiol Heart Circ Physiol 2000; 279: H1757-66.
18. Maxwell AJ, Schauble E, Bernstein D, Cooke JP. Limb blood flow during exercise is dependent upon nitric oxide. Circulation 1998; 98: 369-74.
19. Murray-Rust J, Leiper J, McAlister M et al. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001; 8: 679-83.
20. Lin KY, Ito A, Asagami T et al. Dysregulation of dimethylarginine dimethylaminohydrolase: a mechanism for endothelial dysfunction in diabetes mellitus. Circulation 2002; 106: 987-92.
21. Stuhlinger MC, Tsao PS, Her J-H, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the NO synthase pathway - role of asymmetric dimethylarginine. Circulation 2001; 104: 2569-75.
22. Cooke JP. Asymmetrical dimethylarginine: the Uber marker? Circulation 2004; 109: 1813-18.
23. Van Belle E, Rivard A, Chen D et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997; 96: 2667-74.
24. Jang J, Ho H-K, Kwan HH, Adimoolam S, Fajardo LF, Cooke JP. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 2000; 102: 1414-19.
25. Duan J, Murohara T, Ikeda H et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 2000; 102 (suppl 3): III370-76.
26. Couffinhal T, Silver M, Kearney M et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in Apo E-/-mice. Circulation 1999; 99: 3188-98.
27. Rossig L, Fichtlscherer B, Breitschopf K et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999; 274: 6823-26.
28. Dulak J, Jozkowicz A, Dembinska-Kiec A et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-66.
29. Ziche M, Parenti A, Ledda F et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res 1997; 80: 845-52.
30. Noiri E, Lee E, Testa J et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 1998; 274 (1 Pt 1): C236-44.
31. Kostourou V, Robinson SP, Cartwright JE, Whitley GS. Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. Br J Cancer 2002; 87: 673-80.